Leading science, pioneering therapies
CRM Publications

JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.

TitleJAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.
Publication TypeJournal Article
Year of Publication2010
AuthorsLi J, Spensberger D, Ahn JSook, Anand S, Beer PA, Ghevaert C, Chen E, Forrai A, Scott LM, Ferreira R, Campbell PJ, Watson SP, Liu P, Erber WN, Huntly BJP, Ottersbach K, Green AR
JournalBlood
Volume116
Issue9
Pagination1528-38
Date Published2010 Sep 2
ISSN1528-0020
KeywordsAnimals, Apoptosis, Blotting, Western, Bone Marrow Transplantation, Cell Cycle, Cell Proliferation, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Gene Knock-In Techniques, Hematopoietic Stem Cells, Humans, Integrases, Janus Kinase 2, Mice, Point Mutation, Reverse Transcriptase Polymerase Chain Reaction, RNA, Messenger, Thrombocythemia, Essential
Abstract

The JAK2 V617F mutation is found in most patients with a myeloproliferative neoplasm and is sufficient to produce a myeloproliferative phenotype in murine retroviral transplantation or transgenic models. However, several lines of evidence suggest that disease phenotype is influenced by the level of mutant JAK2 signaling, and we have therefore generated a conditional knock-in mouse in which a human JAK2 V617F is expressed under the control of the mouse Jak2 locus. Human and murine Jak2 transcripts are expressed at similar levels, and mice develop modest increases in hemoglobin and platelet levels reminiscent of human JAK2 V617F-positive essential thrombocythemia. The phenotype is transplantable and accompanied by increased terminal erythroid and megakaryocyte differentiation together with increased numbers of clonogenic progenitors, including erythropoietin-independent erythroid colonies. Unexpectedly, JAK2(V617F) mice develop reduced numbers of lineage(-)Sca-1(+)c-Kit(+) cells, which exhibit increased DNA damage, reduced apoptosis, and reduced cell cycling. Moreover, competitive bone marrow transplantation studies demonstrated impaired hematopoietic stem cell function in JAK2(V617F) mice. These results suggest that the chronicity of human myeloproliferative neoplasms may reflect a balance between impaired hematopoietic stem cell function and the accumulation of additional mutations.

DOI10.1182/blood-2009-12-259747
Alternate JournalBlood
PubMed ID20489053
PubMed Central IDPMC3145111
Grant List088340 / / Wellcome Trust / United Kingdom
FS/09/039/27788 / / British Heart Foundation / United Kingdom
FS09039 / / British Heart Foundation / United Kingdom
G0800784 / / Medical Research Council / United Kingdom
G116/187 / / Medical Research Council / United Kingdom
Publication institute
Other